Stem Cell Technologies' Contract Assay Service Presents an Educational Webinar on the Use of Bone Marrow Assays in Human Toxicity Testing During Drug Development

High content assays for efficient and cost effective preclinical and Phase I drug development.

Vancouver, B.C. (PRWEB) June 26, 2006 -- Stem Cell Technologies (STI), a world leader in the development of technologies for stem cell biology, is pleased to announce that STI Contract Assay Services (www.contractassay.com) will be providing a free, educational webinar on Human Bone Marrow Toxicity testing.

“Toxicity Testing: What Bone Marrow Can Tell Us”, will be presented by Dr. Emer Clarke on July 13, 2006 at 11:00 AM PST (2:00 PM EST). Register online by visiting https://intercallcanada.webex.com/intercallcanada/j.php?ED=91310172&UID=41921737.

Drug Screening with Primary Cells

Cultured primary cells possess characteristics that often represent in vivo physiology better than immortalized cell lines. Thus, primary cell-based assays could give a more accurate prediction of the activity of compounds in in vivo models and in the clinic, and thus could contribute to a decrease in attrition in the whole process of drug discovery.

Bone marrow progenitor assays are more informative than cell proliferation methods; less expensive and faster than in vivo models; and are highly reproducible. One of these assays, the CFC (colony forming cell) assay, is a more effective and cost-saving method for developing dosing strategies for Phase I clinical trials and is the only assay recognized by a regulatory body (ECVAM http://ecvam.jrc.it/) as a method to predict toxicity in phase I drug development.

To register for this event, please visit https://intercallcanada.webex.com/intercallcanada/j.php?ED=91310172&UID=41921737.

About Stemcell Technologies Inc. Contract Services

StemCell Technologies is a world leader in the development of products for stem cell biology and has worked to standardize the field through the Global Proficiency Testing Program. Combining StemCell Technologies' industry standard reagents and a scientific team of experts in hematopoiesis and stem cell biology, StemCell Technologies is proud to assist organizations in drug development, agrochemical production, environmental toxicant testing and the research community by offering Contract Assay Services.

Contact

Rob Chaney

Director of Business Development, STI Contract Assay Service

509.456.3725

# # #